SERT and NET polymorphisms, temperament and antidepressant response

References

• Barker EL, Blakely RD. Norepinephrine and serotonin transporters: Molecular targets of antidepressant drugs. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology. A fourth generation of progress. New York: Raven Press; 1995. p. 321–33.
   Google Scholar
• Bruss M, Kunz J, Lingen B, Bonisch H. Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter. Hum Genet 1993;91:278–280.
   PubMed Web of Science ®Google Scholar
• Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996;66:2621–2624.
   PubMed Web of Science ®Google Scholar
• Gerra G, Zaimovic A, Timpano M, Zambelli U, Delsignore R, Brambilla F. Neuroendocrine correlates of temperamental traits in humans. Psychoneuroendocrinology 2000;25:479–496.
   PubMed Web of Science ®Google Scholar
• Ressler KJ, Nemeroff CB. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 2000;12:2–19.
   PubMed Web of Science ®Google Scholar
• Hahn MK, Mazei-Robison MS, Blakely RD. Single nucleotide polymorphisms in the human norepinephrine transporter gene affect expression, trafficking, antidepressant interaction, and protein kinase C regulation. Mol Pharmacol 2005;68:457–466.
   PubMed Web of Science ®Google Scholar
• Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993;50:975–990.
   PubMed Web of Science ®Google Scholar
• De Fruyt F, Van De Wiele L, Van Heeringen C. Cloninger's psychobiological model of temperament and character and the five-factor model of personality. Pers Indiv Diff 2000;29:441–452.
   Web of Science ®Google Scholar
• Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev 1986;4:167–226.
   PubMedGoogle Scholar
• Zill P, Engel R, Baghai TC, Juckel G, Frodl T, Muller-Siecheneder F, et al. Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression. Neuropsychopharmacology 2002;26:489–493.
   PubMed Web of Science ®Google Scholar
• Stober G, Nothen MM, Porzgen P, Bruss M, Bonisch H, Knapp M, et al. Systematic search for variation in the human norepinephrine transporter gene: Identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet 1996;67:523–532.
   PubMed Web of Science ®Google Scholar
• Chang CC, Lu RB, Chen CL, Chu CM, Chang HA, Huang CC, et al. Lack of association between the norepinephrine transporter gene and major depression in a Han Chinese population. J Psychiatry Neurosci 2007;32:121–128.
   PubMed Web of Science ®Google Scholar
• Buttenschon HN, Jacobsen IS, Grynderup MB, Hansen AM, Kolstad HA, Kaerlev L, et al. An association study between the norepinephrine transporter gene and depression. Psychiatr Genet 2013;23:217–221.
   PubMed Web of Science ®Google Scholar
• Zhao X, Huang Y, Ma H, Jin Q, Wang Y, Zhu G. Association between major depressive disorder and the norepinephrine transporter polymorphisms T-182C and G1287A: A meta-analysis. J Affect Disord 2013;150:23–28.
   PubMed Web of Science ®Google Scholar
• Singh AB, Bousman CA, Ng CH, Byron K, Berk M. Psychomotor depressive symptoms may differentially respond to venlafaxine. Int Clin Psychopharmacol 2013;28:121–126.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Takahashi H, Higuchi H, Kamata M, Ito K, Sato K, et al. Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. Am J Psychiatry 2004;161:1575–1580.
   PubMed Web of Science ®Google Scholar
• Ryu SH, Lee SH, Lee HJ, Cha JH, Ham BJ, Han CS, et al. Association between norepinephrine transporter gene polymorphism and major depression. Neuropsychobiology 2004;49:174–177.
   PubMed Web of Science ®Google Scholar
• Inoue K, Itoh K, Yoshida K, Shimizu T, Suzuki T. Positive association between T-182C polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population. Neuropsychobiology 2004;50:301–304.
   PubMed Web of Science ®Google Scholar
• Hahn MK, Blackford JU, Haman K, Mazei-Robison M, English BA, Prasad HC, et al. Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Genes Brain Behav 2008;7:487–495.
   PubMed Web of Science ®Google Scholar
• Min WJ, Ma XH, Li T, Zhang B, Sun XL. Association of serotonin and norepinephrine transporter gene polymorphisms with the susceptibility to depression. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2009;26:388–392.
   PubMedGoogle Scholar
• Samochowiec J, Rybakowski F, Czerski P, Zakrzewska M, Stepien G, Pelka-Wysiecka J, et al. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationship to temperamental dimensions measured by the Temperament and Character Inventory in healthy volunteers. Neuropsychobiology 2001;43:248–253.
   PubMed Web of Science ®Google Scholar
• Ham BJ, Choi MJ, Lee HJ, Kang RH, Lee MS. Reward dependence is related to norepinephrine transporter T-182C gene polymorphism in a Korean population. Psychiatr Genet 2005;15:145–147.
   PubMed Web of Science ®Google Scholar
• Yamano E, Isowa T, Nakano Y, Matsuda F, Hashimoto-Tamaoki T, Ohira H, et al. Association study between reward dependence temperament and a polymorphism in the phenylethanolamine N-methyltransferase gene in a Japanese female population. Compr Psychiatry 2008;49:503–507.
   PubMed Web of Science ®Google Scholar
• Ebstein RP. The molecular genetic architecture of human personality: Beyond self-report questionnaires. Mol Psychiatry 2006;11:427–445.
   PubMed Web of Science ®Google Scholar
• Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527–1531.
   PubMed Web of Science ®Google Scholar
• Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 1998;3:508–511.
   PubMed Web of Science ®Google Scholar
• Zanardi R, Serretti A, Rossini D, Franchini L, Cusin C, Lattuada E, et al. Factors affecting fluvoxamine antidepressant activity: Influence of pindolol and 5-HTTLPR in delusional and nondelusional depression. Biol Psychiatry 2001;50:323–330.
   PubMed Web of Science ®Google Scholar
• Zanardi R, Benedetti F, Di Bella D, Catalano M, Smeraldi E. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J Clin Psychopharmacol 2000;20:105–107.
   PubMed Web of Science ®Google Scholar
• Pollock BG, Ferrell RE, Mulsant BH, Mazumdar S, Miller M, Sweet RA, et al. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 2000;23:587–590.
   PubMed Web of Science ®Google Scholar
• Serretti A, Benedetti F, Zanardi R, Smeraldi E. The influence of serotonin transporter promoter polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:1074–1084.
   PubMed Web of Science ®Google Scholar
• Yu YW, Tsai SJ, Chen TJ, Lin CH, Hong CJ. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 2002;7:1115–1119.
   PubMed Web of Science ®Google Scholar
• Arias B, Catalan R, Gasto C, Gutierrez B, Fananas L. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. J Clin Psychopharmacol 2003;23:563–567.
   PubMed Web of Science ®Google Scholar
• Serretti A, Kato M, De Ronchi D, Kinoshita T. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 2007;12:247–257.
   PubMed Web of Science ®Google Scholar
• Illi A, Poutanen O, Setala-Soikkeli E, Kampman O, Viikki M, Huhtala H, et al. Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD? Eur Arch Psychiatry Clin Neurosci 2011;261:95–102.
   PubMed Web of Science ®Google Scholar
• Kim DK, Lim SW, Lee S, Sohn SE, Kim S, Hahn CG, et al. Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 2000;11:215–219.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Ito K, Sato K, Takahashi H, Kamata M, Higuchi H, et al. Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:383–386.
   PubMed Web of Science ®Google Scholar
• Kim H, Lim SW, Kim S, Kim JW, Chang YH, Carroll BJ, et al. Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression. JAMA 2006;296:1609–1618.
   PubMed Web of Science ®Google Scholar
• Lewis G, Mulligan J, Wiles N, Cowen P, Craddock N, Ikeda M, et al. Polymorphism of the 5-HT transporter and response to antidepressants: Randomised controlled trial. Br J Psychiatry 2011;198:464–471.
   PubMed Web of Science ®Google Scholar
• Taylor MJ, Sen S, Bhagwagar Z. Antidepressant response and the serotonin transporter gene-linked polymorphic region. Biol Psychiatry 2010;68:536–543.
   PubMed Web of Science ®Google Scholar
• Munafo MR, Freimer NB, Ng W, Ophoff R, Veijola J, Miettunen J, et al. 5-HTTLPR genotype and anxiety-related personality traits: A meta-analysis and new data. Am J Med Genet B Neuropsychiatr Genet 2009;150B:271–281.
   PubMed Web of Science ®Google Scholar
• Minelli A, Bonvicini C, Scassellati C, Sartori R, Gennarelli M. The influence of psychiatric screening in healthy populations selection: A new study and meta-analysis of functional 5-HTTLPR and rs25531 polymorphisms and anxiety-related personality traits. BMC Psychiatry 2011;11:50.
   PubMed Web of Science ®Google Scholar
• Costa PT, Jr, McCrae RR. Stability and change in personality assessment: The revised NEO Personality Inventory in the year 2000. J Pers Assess 1997;68:86–94.
   PubMed Web of Science ®Google Scholar
• Mandelli L, Mazza M, Martinotti G, Di Nicola M, Tavian D, Colombo E, et al. Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients. J Affect Disord 2009;119:205–209.
   PubMed Web of Science ®Google Scholar
• Tomita T, Ishioka M, Kaneda A, Sugawara N, Nakagami T, Nakamura K, Yasui-Furukori N. An investigation of Temperament and Character Inventory items for predicting the response to paroxetine treatment in patients with major depressive disorder. J Affect Disord. 2014;165:109–13.
   PubMed Web of Science ®Google Scholar
• Spittlehouse JK, Vierck E, Pearson JF, Joyce PR. Temperament and character as determinants of well-being. Compr Psychiatry. 2014;55:1679–87.
   PubMed Web of Science ®Google Scholar
• Kaneda A, Yasui-Furukori N, Nakagami T, Sato Y, Kaneko S. The influence of personality factors on paroxetine response time in patients with major depression. J Affect Disord. 2011;135:321–5.
   PubMed Web of Science ®Google Scholar
• Hruby R, Nosalova G, Hruba S. Predictive significance of TCI-R for antidepressant treatment. Med Sci Monit. 2010;16:CR383–8.
   Google Scholar
• Kampman O, Poutanen O. Can onset and recovery in depression be predicted by temperament? A systematic review and meta-analysis. J Affect Disord. 2011;135:20–7.
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–389.
   PubMed Web of Science ®Google Scholar
• Dupont WD, Plummer WD, Jr. Power and sample size calculations for studies involving linear regression. Control Clin Trials 1998;19:589–601.
   PubMedGoogle Scholar
• Cloninger CR, Zohar AH, Hirschmann S, Dahan D. The psychological costs and benefits of being highly persistent: Personality profiles distinguish mood disorders from anxiety disorders. J Affect Disord 2012;136:758–766.
   PubMed Web of Science ®Google Scholar
• Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386–389.
   PubMed Web of Science ®Google Scholar
• Karg K, Burmeister M, Shedden K, Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: Evidence of genetic moderation. Arch Gen Psychiatry 2011;68:444–454.
   PubMed Web of Science ®Google Scholar
• Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J, et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: A meta-analysis. JAMA 2009;301:2462–2471.
   PubMed Web of Science ®Google Scholar
• Munafo MR, Durrant C, Lewis G, Flint J. Gene X environment interactions at the serotonin transporter locus. Biol Psychiatry 2009;65:211–219.
   PubMed Web of Science ®Google Scholar
• Kenna GA, Roder-Hanna N, Leggio L, Zywiak WH, Clifford J, Edwards S, et al. Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: Review of psychopathology and pharmacotherapy. Pharmgenomics Pers Med 2012;5:19–35.
   PubMedGoogle Scholar
• Williams RB, Marchuk DA, Gadde KM, Barefoot JC, Grichnik K, Helms MJ, et al. Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology 2003;28:533–541.
   PubMed Web of Science ®Google Scholar
• Gonda X, Fountoulakis KN, Juhasz G, Rihmer Z, Lazary J, Laszik A, et al. Association of the s allele of the 5-HTTLPR with neuroticism-related traits and temperaments in a psychiatrically healthy population. Eur Arch Psychiatry Clin Neurosci 2009;259:106–113.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Lee MS, Kang RH, Kim H, Kim SD, Kee BS, et al. Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depress Anxiety 2005;21:135–139.
   PubMed Web of Science ®Google Scholar
• Wang Z, Baker DG, Harrer J, Hamner M, Price M, Amstadter A. The relationship between combat-related posttraumatic stress disorder and the 5-HTTLPR/rs25531 polymorphism. Depress Anxiety 2011;28:1067–1073.
   PubMed Web of Science ®Google Scholar
• Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Brady K, et al. Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry 2009;66:1201–1209.
   PubMed Web of Science ®Google Scholar
• Thakur GA, Joober R, Brunet A. Development and persistence of posttraumatic stress disorder and the 5-HTTLPR polymorphism. J Trauma Stress 2009;22:240–243.
   PubMed Web of Science ®Google Scholar
• Grabe HJ, Spitzer C, Schwahn C, Marcinek A, Frahnow A, Barnow S, et al. Serotonin transporter gene (SLC6A4) promoter polymorphisms and the susceptibility to posttraumatic stress disorder in the general population. Am J Psychiatry 2009;166:926–933.
   PubMed Web of Science ®Google Scholar
• Mushtaq D, Ali A, Margoob MA, Murtaza I, Andrade C. Association between serotonin transporter gene promoter-region polymorphism and 4- and 12-week treatment response to sertraline in posttraumatic stress disorder. J Affect Disord 2012;136:955–962.
   PubMed Web of Science ®Google Scholar
• Price JS, Strong J, Eliassen J, McQueeny T, Miller M, Padula CB, et al. Serotonin transporter gene moderates associations between mood, memory and hippocampal volume. Behav Brain Res 2013;242:158–165.
   PubMed Web of Science ®Google Scholar
• Zilles D, Meyer J, Schneider-Axmann T, Ekawardhani S, Gruber E, Falkai P, et al. Genetic polymorphisms of 5-HTT and DAT but not COMT differentially affect verbal and visuospatial working memory functioning. Eur Arch Psychiatry Clin Neurosci 2012;262:667–676.
   PubMed Web of Science ®Google Scholar
• Mannie ZN, Barnes J, Bristow GC, Harmer CJ, Cowen PJ. Memory impairment in young women at increased risk of depression: Influence of cortisol and 5-HTT genotype. Psychol Med 2009;39:757–762.
   PubMed Web of Science ®Google Scholar
• Larsen MB, Sonders MS, Mortensen OV, Larson GA, Zahniser NR, Amara SG. Dopamine transport by the serotonin transporter: A mechanistically distinct mode of substrate translocation. J Neurosci. 2011;31:6605–15.
   PubMed Web of Science ®Google Scholar
• Szekely A, Ronai Z, Nemoda Z, Kolmann G, Gervai J, Sasvari-Szekely M. Human personality dimensions of persistence and harm avoidance associated with DRD4 and 5-HTTLPR polymorphisms. Am J Med Genet B Neuropsychiatr Genet 2004;126B:106–110.
   PubMed Web of Science ®Google Scholar
• Strobel A, Lesch KP, Jatzke S, Paetzold F, Brocke B. Further evidence for a modulation of novelty seeking by DRD4 exon III, 5-HTTLPR, and COMT val/met variants. Mol Psychiatry 2003;8:371–372.
   PubMed Web of Science ®Google Scholar
• Benjamin J, Osher Y, Lichtenberg P, Bachner-Melman R, Gritsenko I, Kotler M, et al. An interaction between the catechol O-methyltransferase and serotonin transporter promoter region polymorphisms contributes to tridimensional personality questionnaire persistence scores in normal subjects. Neuropsychobiology 2000;41:48–53.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kim YS, Lee HS, Kim SY, Kim CH. An interaction between the serotonin transporter promoter region and dopamine transporter polymorphisms contributes to harm avoidance and reward dependence traits in normal healthy subjects. J Neural Transm 2006;113:877–886.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Matsumoto Y, Oshino S, Kamata M, Goto K, Otani K. Combination of the serotonin transporter and norepinephrine transporter gene promoter polymorphisms might influence harm avoidance and novelty seeking in healthy females. Neurosci Lett 2008;439:52–55.
   PubMed Web of Science ®Google Scholar
• Kampman O, Poutanen O. Can onset and recovery in depression be predicted by temperament? A systematic review and meta-analysis. J Affect Disord 2011;135:20–27.
   PubMed Web of Science ®Google Scholar